$1.77
+0.12 (+7.27%)
Open$1.66
Previous Close$1.65
Day High$1.80
Day Low$1.58
52W High$3.22
52W Low$0.91
Volume—
Avg Volume5.54M
Market Cap81.82M
P/E Ratio—
EPS$-0.26
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+2,361.6% upside
Current
$1.77
$1.77
Target
$43.57
$43.57
$34.30
$43.57 avg
$49.66
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 45.2K | 65.8K | 9.20M |
| Net Income | -12,428,880 | -16,301,358 | -2,830,498 |
| Profit Margin | -27,235.7% | -25,873.9% | -30.8% |
| EBITDA | -12,494,137 | -17,297,333 | -2,581,372 |
| Free Cash Flow | — | — | -3,568,526 |
| Rev Growth | -31.4% | -31.4% | +9.2% |
| Debt/Equity | — | — | 0.31 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |